Verify regulatory 503A compliance and calculate out-of-pocket savings for compounded Tirzepatide & Semaglutide in New York compared to retail commercial list prices ($1050/mo).
Status: Available via Registered 503A Facilities with NYS License
New York enforces stringent nonresident pharmacy registration requirements. Only out-of-state 503A compounding pharmacies specifically registered with the NYS Education Department may ship compounded medications to New York residents.
Statutory Citation: N.Y. Educ. Law § 6810 & NYS Board of Pharmacy Regulations Part 63
New York enforces stringent nonresident pharmacy registration requirements. Only out-of-state 503A compounding pharmacies specifically registered with the NYS Education Department may ship compounded medications to New York residents.
Yes, but only if the compounding pharmacy holds an active Nonresident Establishment Registration issued by the New York State Board of Pharmacy.
Browse deep clinical analysis and metabolic decision models on Groundwork.